Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 45 studies | 45% ± 18% | |
macrophage | 38 studies | 37% ± 13% | |
classical monocyte | 23 studies | 36% ± 13% | |
astrocyte | 19 studies | 39% ± 17% | |
non-classical monocyte | 17 studies | 27% ± 9% | |
monocyte | 16 studies | 29% ± 9% | |
oligodendrocyte precursor cell | 15 studies | 55% ± 20% | |
pericyte | 15 studies | 23% ± 11% | |
smooth muscle cell | 13 studies | 25% ± 9% | |
connective tissue cell | 13 studies | 37% ± 14% | |
microglial cell | 12 studies | 37% ± 15% | |
myeloid cell | 11 studies | 35% ± 13% | |
myofibroblast cell | 11 studies | 29% ± 12% | |
adipocyte | 11 studies | 53% ± 17% | |
alveolar macrophage | 8 studies | 49% ± 17% | |
endothelial cell | 8 studies | 38% ± 15% | |
GABAergic neuron | 7 studies | 39% ± 17% | |
glutamatergic neuron | 7 studies | 37% ± 21% | |
basal cell | 6 studies | 32% ± 21% | |
conventional dendritic cell | 6 studies | 23% ± 5% | |
interneuron | 6 studies | 34% ± 18% | |
abnormal cell | 5 studies | 48% ± 14% | |
neuron | 5 studies | 29% ± 8% | |
adventitial cell | 5 studies | 59% ± 6% | |
dendritic cell | 5 studies | 25% ± 8% | |
mesothelial cell | 5 studies | 21% ± 8% | |
mononuclear phagocyte | 5 studies | 26% ± 10% | |
Mueller cell | 5 studies | 23% ± 5% | |
hepatocyte | 5 studies | 39% ± 17% | |
granule cell | 4 studies | 24% ± 7% | |
epithelial cell | 4 studies | 36% ± 19% | |
intermediate monocyte | 4 studies | 40% ± 13% | |
glial cell | 3 studies | 23% ± 8% | |
placental villous trophoblast | 3 studies | 25% ± 8% | |
retinal pigment epithelial cell | 3 studies | 30% ± 13% | |
tissue-resident macrophage | 3 studies | 32% ± 12% | |
muscle cell | 3 studies | 20% ± 4% | |
chondrocyte | 3 studies | 29% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 34421.03 | 1438 / 1445 | 98% | 91.11 | 180 / 183 |
liver | 99% | 35020.40 | 223 / 226 | 99% | 71.99 | 401 / 406 |
intestine | 100% | 33051.51 | 964 / 966 | 96% | 65.08 | 508 / 527 |
lung | 100% | 52772.87 | 576 / 578 | 95% | 66.49 | 1096 / 1155 |
breast | 100% | 64732.08 | 458 / 459 | 95% | 71.08 | 1057 / 1118 |
brain | 93% | 24388.74 | 2463 / 2642 | 100% | 167.44 | 704 / 705 |
skin | 99% | 59049.67 | 1788 / 1809 | 93% | 58.44 | 440 / 472 |
uterus | 100% | 59007.20 | 170 / 170 | 89% | 59.04 | 409 / 459 |
prostate | 98% | 28369.19 | 240 / 245 | 88% | 42.20 | 444 / 502 |
bladder | 100% | 41303.14 | 21 / 21 | 85% | 43.79 | 430 / 504 |
ovary | 100% | 76667.94 | 180 / 180 | 84% | 42.91 | 362 / 430 |
thymus | 99% | 30288.65 | 646 / 653 | 80% | 30.69 | 482 / 605 |
stomach | 69% | 18603.28 | 249 / 359 | 97% | 76.11 | 276 / 286 |
adrenal gland | 86% | 15519.04 | 222 / 258 | 72% | 31.90 | 165 / 230 |
kidney | 39% | 7295.73 | 35 / 89 | 85% | 47.70 | 763 / 901 |
pancreas | 18% | 2300.29 | 60 / 328 | 96% | 95.95 | 171 / 178 |
adipose | 100% | 84604.28 | 1204 / 1204 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 14.78 | 1 / 1 |
blood vessel | 100% | 76741.52 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 29084.98 | 827 / 861 | 0% | 0 | 0 / 0 |
spleen | 95% | 18401.45 | 230 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 60.21 | 42 / 45 |
eye | 0% | 0 | 0 / 0 | 89% | 43.13 | 71 / 80 |
lymph node | 0% | 0 | 0 / 0 | 55% | 18.25 | 16 / 29 |
muscle | 32% | 4694.74 | 259 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 11% | 1446.75 | 103 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031623 | Biological process | receptor internalization |
GO_0014912 | Biological process | negative regulation of smooth muscle cell migration |
GO_0060392 | Biological process | negative regulation of SMAD protein signal transduction |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0006898 | Biological process | receptor-mediated endocytosis |
GO_0032374 | Biological process | regulation of cholesterol transport |
GO_0150104 | Biological process | transport across blood-brain barrier |
GO_0007041 | Biological process | lysosomal transport |
GO_0007167 | Biological process | enzyme-linked receptor protein signaling pathway |
GO_0032092 | Biological process | positive regulation of protein binding |
GO_0045807 | Biological process | positive regulation of endocytosis |
GO_0010715 | Biological process | regulation of extracellular matrix disassembly |
GO_0002265 | Biological process | astrocyte activation involved in immune response |
GO_0097242 | Biological process | amyloid-beta clearance |
GO_0030178 | Biological process | negative regulation of Wnt signaling pathway |
GO_0001523 | Biological process | retinoid metabolic process |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0043277 | Biological process | apoptotic cell clearance |
GO_0150093 | Biological process | amyloid-beta clearance by transcytosis |
GO_1900223 | Biological process | positive regulation of amyloid-beta clearance |
GO_0150094 | Biological process | amyloid-beta clearance by cellular catabolic process |
GO_0035909 | Biological process | aorta morphogenesis |
GO_0010875 | Biological process | positive regulation of cholesterol efflux |
GO_1904300 | Biological process | positive regulation of transcytosis |
GO_0006909 | Biological process | phagocytosis |
GO_0032370 | Biological process | positive regulation of lipid transport |
GO_0045056 | Biological process | transcytosis |
GO_0042953 | Biological process | lipoprotein transport |
GO_1905049 | Biological process | negative regulation of metallopeptidase activity |
GO_0006629 | Biological process | lipid metabolic process |
GO_1904646 | Biological process | cellular response to amyloid-beta |
GO_1905167 | Biological process | positive regulation of lysosomal protein catabolic process |
GO_0032956 | Biological process | regulation of actin cytoskeleton organization |
GO_0032429 | Biological process | regulation of phospholipase A2 activity |
GO_2000587 | Biological process | negative regulation of platelet-derived growth factor receptor-beta signaling pathway |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005769 | Cellular component | early endosome |
GO_0030666 | Cellular component | endocytic vesicle membrane |
GO_0005815 | Cellular component | microtubule organizing center |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005925 | Cellular component | focal adhesion |
GO_0098797 | Cellular component | plasma membrane protein complex |
GO_0005905 | Cellular component | clathrin-coated pit |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0005634 | Cellular component | nucleus |
GO_0030226 | Molecular function | apolipoprotein receptor activity |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0032050 | Molecular function | clathrin heavy chain binding |
GO_0038024 | Molecular function | cargo receptor activity |
GO_0001540 | Molecular function | amyloid-beta binding |
GO_0005044 | Molecular function | scavenger receptor activity |
GO_0034185 | Molecular function | apolipoprotein binding |
GO_0016964 | Molecular function | alpha-2 macroglobulin receptor activity |
GO_0005041 | Molecular function | low-density lipoprotein particle receptor activity |
GO_0003723 | Molecular function | RNA binding |
GO_0043395 | Molecular function | heparan sulfate proteoglycan binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0070325 | Molecular function | lipoprotein particle receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LRP1 |
Protein name | LDL receptor related protein 1 Alternative protein LRP1 LDL receptor related protein 1 (LRP1 protein) Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] |
Synonyms | A2MR APR |
Description | FUNCTION: Endocytic receptor involved in endocytosis and in phagocytosis of apoptotic cells . Required for early embryonic development (By similarity). Involved in cellular lipid homeostasis. Involved in the plasma clearance of chylomicron remnants and activated LRPAP1 (alpha 2-macroglobulin), as well as the local metabolism of complexes between plasminogen activators and their endogenous inhibitors. Acts as an LRPAP1 alpha-2-macroglobulin receptor . Acts as TAU/MAPT receptor and controls the endocytosis of TAU/MAPT as well as its subsequent spread . May modulate cellular events, such as APP metabolism, kinase-dependent intracellular signaling, neuronal calcium signaling as well as neurotransmission . .; FUNCTION: (Microbial infection) Functions as a receptor for Pseudomonas aeruginosa exotoxin A. . |
Accessions | ENST00000338962.8 [Q07954-2] H0YJ88 Q7Z7K9 ENST00000555124.1 ENST00000554174.1 ENST00000553277.5 ENST00000554118.1 Q6PJ72 L0R6J6 H0YJI8 Q07954 ENST00000243077.8 [Q07954-1] |